Literature DB >> 3106416

Inhibition of human endothelial cell proliferation by gold compounds.

T Matsubara, M Ziff.   

Abstract

Neovascularization has a role in the propagation of rheumatoid synovitis because the spread of mononuclear cell infiltration and the growth of pannus are dependent on the growth of new blood vessels. Growth of such vessels requires local endothelial cell (EC) proliferation. Inhibition of synovial EC proliferation, therefore, would have the potential to diminish rheumatoid inflammation. We have, therefore, studied the effects of gold sodium thiomalate (GST), auranofin, and gold chloride on the proliferation of human umbilical vein EC. GST suppressed both basal and EC growth factor-induced tritiated thymidine incorporation into EC in a dose-dependent fashion. Inhibition was observed with concentrations as low as 1 microgram/ml GST, 5 micrograms/ml gold chloride, and 0.1 microgram/ml auranofin, levels attainable in blood and synovium of patients. These results suggest that gold compounds have an antiangiogenic effect. The low concentrations inhibiting EC proliferation suggest that gold compounds may suppress rheumatoid synovitis by reducing the number of small blood vessels available for mononuclear cell infiltration and synovial tissue proliferation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106416      PMCID: PMC424416          DOI: 10.1172/JCI112972

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  Effect of gold salts and other drugs on the release and activity of lysosomal hydrolases.

Authors:  R S Ennis; J L Granda; A S Posner
Journal:  Arthritis Rheum       Date:  1968-12

2.  Serum gold. II. Levels in rheumatoid arthritis.

Authors:  H M Rubinstein; A A Dietz
Journal:  Ann Rheum Dis       Date:  1973-03       Impact factor: 19.103

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Tissue gold concentration in a rheumatoid arthritic receiving chrysotherapy.

Authors:  N L Gottlieb; P M Smith; E M Smith
Journal:  Arthritis Rheum       Date:  1972 Jan-Feb

5.  Effect of anti-arthritic drugs on sulfhydryl reactivity of rat serum.

Authors:  D T Walz; M J DiMartino
Journal:  Proc Soc Exp Biol Med       Date:  1972-05

6.  Gold metabolism in patients with rheumatoid arthritis treated with gold compounds--reinvestigated.

Authors:  B R Mascarenhas; J L Granda; R H Freyberg
Journal:  Arthritis Rheum       Date:  1972 Jul-Aug

7.  Clinical response and serum gold levels in chrysotherapy. Lack of correlation.

Authors:  R C Gerber; H E Paulus; R Bluestone; C M Pearson
Journal:  Ann Rheum Dis       Date:  1972-07       Impact factor: 19.103

8.  Gold determination in biological fluids by atomic absorption spectrophotometry: application to chrysotherapy in rheumatoid arthritis patients.

Authors:  A Lorber; R L Cohen; C C Chang; H E Anderson
Journal:  Arthritis Rheum       Date:  1968-04

9.  Investigations on the reaction of metals with collagen in vivo. 1. Comparison of the reaction of gold thiosulphate with collagen in vivo and vitro.

Authors:  M Adam; K Kühn
Journal:  Eur J Biochem       Date:  1968-02

10.  Action of gold salts on the inflammatory response and inflammatory cell function.

Authors:  B Vernon-Roberts
Journal:  J Rheumatol Suppl       Date:  1979
View more
  22 in total

1.  Localisation of xanthine oxidase to synovial endothelium.

Authors:  C R Stevens; M Benboubetra; R Harrison; T Sahinoglu; E C Smith; D R Blake
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

2.  Thiol-containing compounds inhibit the production of monocyte/macrophage-derived angiogenic activity.

Authors:  A E Koch; J C Burrows; P J Polverini; M Cho; S J Leibovich
Journal:  Agents Actions       Date:  1991-11

3.  The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin.

Authors:  S Gately; P Twardowski; M S Stack; D L Cundiff; D Grella; F J Castellino; J Enghild; H C Kwaan; F Lee; R A Kramer; O Volpert; N Bouck; G A Soff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

4.  Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine.

Authors:  T Matsubara; R Saura; K Hirohata; M Ziff
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

Review 5.  Antiangiogenesis as a novel therapeutic concept in pediatric oncology.

Authors:  L Schweigerer
Journal:  J Mol Med (Berl)       Date:  1995-10       Impact factor: 4.599

6.  The effect of auranofin and sulphasalazine therapy on circulating levels of interleukin 6 in rheumatoid arthritis patients.

Authors:  A Crilly; H A Capell; J Watson; R Madhok
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

7.  Endothelial proliferation in experimental granulomatous colitis. Autoradiography and immunohistochemistry studies.

Authors:  N Pooley; L Ghosh; J Blanchard; P Sharon
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

8.  Immunomodulatory effects of therapeutic gold compounds. Gold sodium thiomalate inhibits the activity of T cell protein kinase C.

Authors:  K Hashimoto; C E Whitehurst; T Matsubara; K Hirohata; P E Lipsky
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

9.  Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist.

Authors:  C M Storgard; D G Stupack; A Jonczyk; S L Goodman; R I Fox; D A Cheresh
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

10.  Serum concentrations of soluble interleukin 2 receptor in patients with rheumatoid arthritis: effect of second line drugs.

Authors:  A Crilly; R Madhok; J Watson; H A Capell
Journal:  Ann Rheum Dis       Date:  1993-01       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.